Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
about
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety and efficacy of abexino ...... a: results of a phase II study
@ast
Safety and efficacy of abexino ...... a: results of a phase II study
@en
type
label
Safety and efficacy of abexino ...... a: results of a phase II study
@ast
Safety and efficacy of abexino ...... a: results of a phase II study
@en
prefLabel
Safety and efficacy of abexino ...... a: results of a phase II study
@ast
Safety and efficacy of abexino ...... a: results of a phase II study
@en
P2093
P2860
P1433
P1476
Safety and efficacy of abexino ...... a: results of a phase II study
@en
P2093
Arpad Illes
Bernard Lemieux
Bertrand Coiffier
Franck Morschhauser
Fritz Offner
Ioana Kloos
Reda Bouabdallah
Remus Vezan
Soon Thye Lim
Thorsten Graef
P2860
P304
P356
10.3324/HAEMATOL.2016.154377
P50
P577
2017-01-25T00:00:00Z